Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Porcellati

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Investigation|June 1, 1994
Effects of glucose on sorbitol pathway activation, cellular redox, and metabolism of myo-inositol, phosphoinositide, and diacylglycerol in cultured human retinal pigment epithelial cellsT P Thomas, F Porcellati, K Kato, et al.
Diabetes & Metabolism|June 11, 2017
Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetesP Lucidi, F Porcellati, A Marinelli Andreoli, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 23, 2004
Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulinF Porcellati, P Rossetti, S Pampanelli, et al.
Diabetes, Obesity & Metabolism|January 6, 2011
Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetesG B Bolli, S Luzio, S Marzotti, et al.
The Journal of Clinical Investigation|June 1, 1992
Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysisC G Fanelli, P De Feo, F Porcellati, et al.
Diabetes|July 1, 1993
Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathyF Porcellati, C Fanelli, P Bottini, et al.
Diabetologia|December 13, 2006
Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemiaF Porcellati, S Pampanelli, P Rossetti, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitusL Epifano, A Di Vincenzo, C Fanelli, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 8, 2014
Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: a dose-response studyP Lucidi, F Porcellati, P Candeloro, et al.
Diabetes|December 16, 2000
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lisproM Lepore, S Pampanelli, C Fanelli, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Investigation|June 1, 1994
Effects of glucose on sorbitol pathway activation, cellular redox, and metabolism of myo-inositol, phosphoinositide, and diacylglycerol in cultured human retinal pigment epithelial cellsT P Thomas, F Porcellati, K Kato, et al.
Diabetes & Metabolism|June 11, 2017
Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetesP Lucidi, F Porcellati, A Marinelli Andreoli, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 23, 2004
Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulinF Porcellati, P Rossetti, S Pampanelli, et al.
Diabetes, Obesity & Metabolism|January 6, 2011
Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetesG B Bolli, S Luzio, S Marzotti, et al.
The Journal of Clinical Investigation|June 1, 1992
Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysisC G Fanelli, P De Feo, F Porcellati, et al.
Diabetes|July 1, 1993
Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathyF Porcellati, C Fanelli, P Bottini, et al.
Diabetologia|December 13, 2006
Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemiaF Porcellati, S Pampanelli, P Rossetti, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitusL Epifano, A Di Vincenzo, C Fanelli, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 8, 2014
Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: a dose-response studyP Lucidi, F Porcellati, P Candeloro, et al.
Diabetes|December 16, 2000
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lisproM Lepore, S Pampanelli, C Fanelli, et al.
Pageof 3